Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy.

Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy. Abstract Text:

    eisaku higuchiEisaku Higuchi,nobuhiko oridateNobuhiko Oridate,akihiro hommaAkihiro Homma,fumiyuki suzukiFumiyuki Suzuki,yoshihiro atagoYoshihiro Atago,tatsumi nagahashiTatsumi Nagahashi,yasushi furutaYasushi Furuta,satoshi fukudaSatoshi Fukuda,eisaku higuchiEisaku Higuchi,nobuhiko oridateNobuhiko Oridate,akihiro hommaAkihiro Homma,fumiyuki suzukiFumiyuki Suzuki,yoshihiro atagoYoshihiro Atago,tatsumi nagahashiTatsumi Nagahashi,yasushi furutaYasushi Furuta,satoshi fukudaSatoshi Fukuda,

    BACKGROUND: The current study aimed to evaluate the significance of the cell-cycle-control proteins cyclin D1 and p16 as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with docetaxel and radiotherapy. METHODS: Cyclin D1 and/or p16 protein expression was retrospectively evaluated by immunohistochemistry in 53 patients with stage T1-3N0-2M0 (except T1N0 glottis) HNSCC who were treated with 10 mg/m(2)/week docetaxel 4 to 6 times and received concurrent chemoradiotherapy. RESULTS: Kaplan-Meier univariate analysis revealed that patients with cyclin D1-positive tumors or p16-negative tumors had a worse prognosis compared with those with cyclin D1-negative tumors or p16-positive tumors (p = .0004 and p = .025, respectively). The prognostic significance of cyclin D1 expression, not p16 expression, was confirmed using a proportional hazard regression model. CONCLUSIONS: An assessment of cyclin D1 and p16 levels might be of clinical use in defining subgroups of patients with poor prognosis.

    Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy. Publishing Authors By Initials

    e higuchiE Higuchi,n oridateN Oridate,a hommaA Homma,f suzukiF Suzuki,y atagoY Atago,t nagahashiT Nagahashi,y furutaY Furuta,s fukudaS Fukuda,e higuchiE Higuchi,n oridateN Oridate,a hommaA Homma,f suzukiF Suzuki,y atagoY Atago,t nagahashiT Nagahashi,y furutaY Furuta,s fukudaS Fukuda,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Head & neck

    VOLUME: 29

    Page Numbers: 940-7

    Journal Abbreviation: Head Neck

    ISSN: 1043-3074

    DAY: 22

    MONTH: Oct

    YEAR: 2007

    Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8902541

    Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy.

    AFFILIATION: Department of Otolaryngology--Head and Neck Surgery, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Head Neck

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News